393 related articles for article (PubMed ID: 28438935)
21. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
23. [Clinical pathogenesis of candidemia caused by non-albicans Candida species].
Myoken Y
Nihon Ishinkin Gakkai Zasshi; 2009; 50(4):225-8. PubMed ID: 19942793
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.
Wu PF; Liu WL; Hsieh MH; Hii IM; Lee YL; Lin YT; Ho MW; Liu CE; Chen YH; Wang FD
Emerg Microbes Infect; 2017 Oct; 6(10):e87. PubMed ID: 29018251
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Wang H; Xu YC; Hsueh PR
Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
[TBL] [Abstract][Full Text] [Related]
27. A study on Candida biofilm growth characteristics and its susceptibility to aureobasidin A.
Munusamy K; Vadivelu J; Tay ST
Rev Iberoam Micol; 2018; 35(2):68-72. PubMed ID: 29544734
[TBL] [Abstract][Full Text] [Related]
28. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
29. Factors related to outcome of bloodstream infections due to Candida parapsilosis complex.
Barchiesi F; Orsetti E; Osimani P; Catassi C; Santelli F; Manso E
BMC Infect Dis; 2016 Aug; 16():387. PubMed ID: 27507170
[TBL] [Abstract][Full Text] [Related]
30. Surveillance and characterization of Candida bloodstream infections in a Serbian tertiary care hospital.
Stojanovic P; Stojanovic N; Stojanovic-Radic Z; Arsić Arsenijević V; Otasevic S; Randjelovic P; Radulović NS
J Infect Dev Ctries; 2016 Jun; 10(6):643-56. PubMed ID: 27367014
[TBL] [Abstract][Full Text] [Related]
31. Micafungin is more active against Candida albicans biofilms with high metabolic activity.
Marcos-Zambrano LJ; Escribano P; González del Vecchio M; Bouza E; Guinea J
J Antimicrob Chemother; 2014 Nov; 69(11):2984-7. PubMed ID: 24942468
[TBL] [Abstract][Full Text] [Related]
32. Impact of biofilm production by Candida species and antifungal therapy on mortality of patients with candidemia.
Lee CH; Chen YC; Chen IL; Chen FJ; Chien CC
Mycoses; 2020 Dec; 63(12):1382-1391. PubMed ID: 32910518
[TBL] [Abstract][Full Text] [Related]
33. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.
Chi HW; Yang YS; Shang ST; Chen KH; Yeh KM; Chang FY; Lin JC
J Microbiol Immunol Infect; 2011 Oct; 44(5):369-75. PubMed ID: 21524971
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.
Kimura M; Araoka H; Yamamoto H; Asano-Mori Y; Nakamura S; Yamagoe S; Ohno H; Miyazaki Y; Abe M; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Uchida N; Izutsu K; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115352
[TBL] [Abstract][Full Text] [Related]
35. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013.
Rajendran R; Sherry L; Nile CJ; Sherriff A; Johnson EM; Hanson MF; Williams C; Munro CA; Jones BJ; Ramage G
Clin Microbiol Infect; 2016 Jan; 22(1):87-93. PubMed ID: 26432192
[TBL] [Abstract][Full Text] [Related]
36. In vitro biofilm production of Candida bloodstream isolates: any association with clinical characteristics?
Pongrácz J; Benedek K; Juhász E; Iván M; Kristóf K
J Med Microbiol; 2016 Apr; 65(4):272-277. PubMed ID: 26678484
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiology, risk factors and in vitro susceptibility in candidaemia due to non-Candida albicans species].
Marín Martínez EM; Aller García AI; Martín-Mazuelos E
Rev Iberoam Micol; 2016; 33(4):248-252. PubMed ID: 27746090
[TBL] [Abstract][Full Text] [Related]
38. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella.
Marcos-Zambrano LJ; Bordallo-Cardona MÁ; Borghi E; Falleni M; Tosi D; Muñoz P; Escribano P; Guinea J
Med Mycol; 2020 Jan; 58(1):83-92. PubMed ID: 30874807
[TBL] [Abstract][Full Text] [Related]
39. Spectrum and Antifungal Resistance of Candidemia in Neonates With Early- and Late-Onset Sepsis in Pakistan.
Rattani S; Farooqi J; Hussain AS; Jabeen K
Pediatr Infect Dis J; 2021 Sep; 40(9):814-820. PubMed ID: 33941745
[TBL] [Abstract][Full Text] [Related]
40. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.
Calvo B; Melo AS; Perozo-Mena A; Hernandez M; Francisco EC; Hagen F; Meis JF; Colombo AL
J Infect; 2016 Oct; 73(4):369-74. PubMed ID: 27452195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
